glp 1 and addiction GLP-1 Agonists: Expanding Horizons in Treatment GLP-1 Receptor Agonists and Research

We prioritized data from pediatric populations and provided adult data when this was lacking

Now, pharmaceutical companies are racing to develop pill-based alternatives that may be easier to use than injections

GLP-1 inhibits the postprandial increase in triglycerides (TGs) and free fatty acids in patients with diabetes [76]

Because it suggests the medication isn't removing your capacity for joy it's dampening the seeking and anticipation circuits that drive you toward joyful experiences in the first place

Clinical studies such as the GetGoal trial program demonstrated that while it improved glycemic control, its effect on body weight was small (typically 23 kg reduction) and not sufficient to warrant an obesity indication

The medication targets your insulin levels, and as a result, you may end up feeling tired: If blood sugar drops too low, it can cause feelings of tiredness or lethargy, he says